588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
ft538 Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P1	D (25)
Car-Itnk Cells Targeting Cd70 And Cll1 Acute Myeloid Leukemia	Tongji Hospital	Early P1	D (23)
cd70-targeting car-t cells Acute Myeloid Leukemia	Baylor College of Medicine	P1	D (23)
cll1 and cd38 dual-target car-t cell Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	D (23)
Indium In 111-Dota-Daratumumab Acute Myeloid Leukemia	City of Hope Medical Center	P1	D (23)
Xmab18968 Acute Myeloid Leukemia	Ehab L Atallah	P1	D (23)
Anti-Cll-1 Car Nk Cells Acute Myeloid Leukemia	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	P1	D (22)
Anti-Cll1 Cart Cells Acute Myeloid Leukemia	920th Hospital of Joint Logistics Support Force of People's Liberation Army of China	P1/2	D (22)
cd371-specific/ysnvz/i-18 car t cells Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P1	D (22)
cd7-specific car gene-engineered t cells Acute Myeloid Leukemia	Shenzhen Geno-Immune Medical Institute	P1/2	D (22)
cll1 car t-cells Acute Myeloid Leukemia	Tongji Hospital	P1/2	D (22)
Supcd7 Cart Cells Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1/2	D (22)
ucd7 cart Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	D (22)
Wu-Cart-007 Acute Myeloid Leukemia	Washington University School of Medicine	P1	D (22)
b7-h3 target, car gene modified gdt cell Acute Myeloid Leukemia	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	P1	D (21)
cd84-cart Acute Myeloid Leukemia	First Affiliated Hospital of Zhejiang University	Early P1	D (21)
Lilrb4 Star-T Cells Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	N/A	D (21)
nkg2d car t-cells Acute Myeloid Leukemia	Zhejiang University	Early P1	D (21)
Adgre2 Car-T Acute Myeloid Leukemia	Zhejiang University	P1	D (20)
Pcna Inhibitor Aoh1996 Acute Myeloid Leukemia	City of Hope Medical Center	P1	D (20)
Autologous Anti-Cd83 Car T-Cells Acute Myeloid Leukemia	Roswell Park Cancer Institute	P1	D (18)
cd180 cart Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	D (16)
Anti-Lilra6 Car-T Cells Acute Myeloid Leukemia	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	D (15)
Autologous Hla-A*02:01-Restricted Cd4+ T-Cells Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	NR ()
bal0891 Acute Myeloid Leukemia	SillaJen, Inc.	P1	NR ()
Byon4413 Acute Myeloid Leukemia	Byondis B.V.	P1	NR ()
Cctx-001 Acute Myeloid Leukemia	Advesya SAS	P1/2	NR ()
Cll-1 And Cd123 Dual-Target Car-T Cells Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	Early P1	NR ()
ct0991 car-t cells infusicn Acute Myeloid Leukemia	MEI HENG	P1	NR ()
GT737 Acute Myeloid Leukemia	Grit Biotechnology	Early P1	NR ()
Hpb-092 Acute Myeloid Leukemia	Hangzhou Polymed Biopharmaceuticals, Inc.	P1	NR ()
IPN60340 Acute Myeloid Leukemia	Ipsen	P2/3	NR ()
ncr300 Acute Myeloid Leukemia	Nuwacell Biotechnologies Co., Ltd.	P1	NR ()
Nei-01 Acute Myeloid Leukemia	New Epsilon Innovation Limited	P1	NR ()
Plm-102 Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P1	NR ()
s227928 Acute Myeloid Leukemia	Servier Bio-Innovation LLC	P1/2	NR ()
wbc100 qd Acute Myeloid Leukemia	Hangzhou Weben Pharma Co., Ltd	P1	NR ()

Showing 551 to 588 of 588 assets

PreviousPage 12 of 12Next